Key result
A new simplified artificial chordae implantation technique for mitral valve repair yielded no significant mitral regurgitation or need for reoperation over a mean follow-up of 19.3 months.
Why the study?
Although many mitral valve repair techniques report successful long-term results, the authors aimed to present a simplified technique for artificial chordae replacement and report its short-term outcomes.
Does a new simplified artificial chordae implantation technique prevent recurrent mitral regurgitation and MACCE in patients undergoing mitral valve repair?
Observational (n=57)
No
Does a new simplified artificial chordae implantation technique prevent recurrent mitral regurgitation and MACCE in patients undergoing mitral valve repair?
A simplified artificial chordae implantation technique for mitral valve repair demonstrates good short-term outcomes with no significant recurrent mitral regurgitation or need for reoperation at 19 months.
No takes yet. Share an insight, caveat, or question.
May support simplified chordae technique in experienced hands; leaves open durability, generalizability, and need for prospective trials.
Gabry et al. (2020) conducted an observational in Mitral valve pathology requiring repair (n=57). New simplified artificial chordae implantation technique was evaluated on Freedom from mitral regurgitation (MR), reoperation and major adverse cardiac and cerebrovascular events (MACCE). A new simplified artificial chordae implantation technique for mitral valve repair yielded no significant mitral regurgitation or need for reoperation over a mean follow-up of 19.3 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: